327 related articles for article (PubMed ID: 25026415)
1. Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies.
Jain D; Bajaj A; Athawale R; Shrikhande S; Goel PN; Nikam Y; Gude R; Patil S; Prashant Raut P
Drug Deliv; 2016; 23(3):999-1016. PubMed ID: 25026415
[TBL] [Abstract][Full Text] [Related]
2. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
Guo W; Li A; Jia Z; Yuan Y; Dai H; Li H
Eur J Pharmacol; 2013 Oct; 718(1-3):41-7. PubMed ID: 24070814
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
Ling Y; Wei K; Zou F; Zhong S
Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
5. Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation.
Jain A; Chasoo G; Singh SK; Saxena AK; Jain SK
J Microencapsul; 2011; 28(1):21-8. PubMed ID: 21171813
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
Liu D; Wang L; Liu Z; Zhang C; Zhang N
J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
[TBL] [Abstract][Full Text] [Related]
7. In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content.
Sheng Y; Yuan Y; Liu C; Tao X; Shan X; Xu F
J Mater Sci Mater Med; 2009 Sep; 20(9):1881-91. PubMed ID: 19365612
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma.
Li H; Tong Y; Bai L; Ye L; Zhong L; Duan X; Zhu Y
Int J Biol Macromol; 2018 Feb; 107(Pt A):204-211. PubMed ID: 28863897
[TBL] [Abstract][Full Text] [Related]
9. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
10. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
Essa S; Louhichi F; Raymond M; Hildgen P
J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles.
Mainardes RM; Khalil NM; Gremião MP
Int J Pharm; 2010 Aug; 395(1-2):266-71. PubMed ID: 20580792
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles.
Liu M; Li H; Luo G; Liu Q; Wang Y
Arch Pharm Res; 2008 Apr; 31(4):547-54. PubMed ID: 18449515
[TBL] [Abstract][Full Text] [Related]
14. Investigations on pharmacokinetics and biodistribution of polymeric and solid lipid nanoparticulate systems of atypical antipsychotic drug: effect of material used and surface modification.
Joseph E; Saha RN
Drug Dev Ind Pharm; 2017 Apr; 43(4):678-686. PubMed ID: 28044468
[TBL] [Abstract][Full Text] [Related]
15. Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo.
Xing J; Zhang D; Tan T
Int J Biol Macromol; 2007 Jan; 40(2):153-8. PubMed ID: 16901536
[TBL] [Abstract][Full Text] [Related]
16. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
Zhang X; Liu L; Chai G; Zhang X; Li F
Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853
[TBL] [Abstract][Full Text] [Related]
17. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
18. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.
Han L; Ren Y; Long L; Zhong Y; Shen C; Pu P; Yuan X; Kang C
Oncol Rep; 2012 Jan; 27(1):121-8. PubMed ID: 21922149
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro.
Zhang H; Gao S
Int J Pharm; 2007 Feb; 329(1-2):122-8. PubMed ID: 17000068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]